RIL
NUVB icon

Rothschild Investment LLC’s Nuvation Bio NUVB Stock Holding History

Rothschild Investment LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3K Buy
405
+24
+6% +$117 ﹤0.01% 2701
2026
Q1 		$1.63K Buy
381
+93
+32% +$518 ﹤0.01% 2650
2025
Q4 		$2.58K Buy
288
+28
+11% +$173 ﹤0.01% 2236
2025
Q3 		$962 Buy
260
+130
+100% +$354 ﹤0.01% 2594
2025
Q2 		$254 Sell
130
-535
-80% -$1.11K ﹤0.01% 2890
2025
Q1 		$1.17K Buy
665
+570
+600% +$1.3K ﹤0.01% 2246
2024
Q4 		$253 Buy
+95
New +$245 ﹤0.01% 2739

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Rothschild Investment LLC's NUVB Position: Q2 2026 in Review

Rothschild Investment LLC increased its Nuvation Bio (NUVB) stake by 6.3% in Q2 2026, buying an estimated $117 and bringing the position to 405 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Rothschild Investment LLC first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.58K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Rothschild Investment LLC held 405 shares of Nuvation Bio worth $2.3K as of Q2 2026.
  • Rothschild Investment LLC bought 24 Nuvation Bio shares in Q2 2026, an estimated $117.
  • Nuvation Bio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2701 holding.
  • Rothschild Investment LLC first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • Rothschild Investment LLC's Nuvation Bio position peaked at $2.58K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.